Indian states turn to anti-parasitic drug to fight COVID-19 against WHO advice

FILE PHOTO: A health worker rests as he sits next to his ambulance carrying a dead body of a victim who died due to the coronavirus disease (COVID-19), at a crematorium in New Delhi, India, May 10, 2021. REUTERS/Adnan Abidi

BENGALURU (Reuters) - At least two Indian states have said they plan to dose their populations with the anti-parasitic drug ivermectin to protect against severe COVID-19 infections as their hospitals are overrun with patients in critical condition.

The move by the coastal state of Goa and northern state of Uttarakhand, come despite the World Health Organization and others warning against such measures.